Abbott Stock: Medical Giant Shrugs Off 'Middling' Quarter As 2025 Sales Guidance, Diabetes Tech Shine

Abbott Stock: Medical Giant Shrugs Off ‘Middling’ Quarter As 2025 Sales Guidance, Diabetes Tech Shine

Abbott stock reversed early losses Wednesday, shrugging off a “middling” quarter, on its strong sales outlook for 2025 and a bullish fourth-quarter performance from its diabetes devices. ↑ X NOW PLAYING How To Buy Stocks: Profit From Earnings Reports Using This Option Strategy For the full year, Abbott Laboratories (ABT) expects sales to grow 7.5%…

Read More
Intuitive Surgical Stock Breaks Out After Robotic Surgery Giant Crushes Quarterly Forecasts

Intuitive Surgical Stock Breaks Out After Robotic Surgery Giant Crushes Quarterly Forecasts

Intuitive Surgical (ISRG) stock broke out Wednesday after the robotic surgery giant crushed Wall Street’s expectations in its preliminary fourth-quarter report. ↑ X NOW PLAYING How To Buy Stocks: Flat Base Chart Pattern During the December quarter, sales surged 25% to $2.41 billion, the company said. That easily beat forecasts for $2.2 billion, according to…

Read More